OS Therapies Inc. (NYSE American: OSTX), a leader in listeria-based cancer immunotherapies, announced its third quarter 2025 financial results and provided a comprehensive business update. The...
Johnson & Johnson (J&J) has submitted a new application to the U.S. Food and Drug Administration (FDA) to expand the use of its medication, Stelara (ustekinumab),...
Akebia Therapeutics has officially halted its plans to expand the indication for its drug Vafseo (vadadustat), aimed at treating anemia in patients with chronic kidney disease...
Novo Nordisk has secured approval from the U.S. Food and Drug Administration (FDA) to market its oral GLP-1 medication, Rybelsus, specifically aimed at reducing the risk...
MannKind Corporation has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental marketing application for Afrezza, an inhalation powder of human insulin....
Cidara Therapeutics has received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) for its investigational drug, CD388. This treatment targets the prevention of...
New York State has introduced new COVID-19 vaccine guidelines that extend beyond the current authorizations provided by the U.S. Food and Drug Administration (FDA). This initiative,...
The La Salle County Health Department is set to sponsor the 31st Annual Food Service Seminar on September 8, 2023, at Senica’s Oak Ridge in La...
The U.S. Food and Drug Administration (FDA) announced on October 23, 2023, its recommendation to lift the voluntary hold on the gene therapy treatment, Elevidys, developed...
GlaxoSmithKline (GSK) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has extended the review period for its blood cancer therapy, Blenrep. This development...
